Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal
Jonathan Barratt, MD, PhD
An De Vriese, MD, PhD
The Evolving Role of Biomarkers in IgAN
Chee Kay Cheung, MBChB, MRCP, PhD
Navigating KDIGO Guidance in IgAN
Jörg Latus, MD
Translating Evidence into IgAN Care
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
The Future of IgAN Care
Unmasking IgAN: Achieving Earlier Diagnosis
The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
Decoding IgA Nephropathy: From Suspicion to Solution
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
When Itching Hurts: Quality of Life Disruption in CKD-aP
Nancy Helou, PhD
Steven Fishbane, MD
CKD-aP Uncovered Prevalence & Pathophysiology
Reading Between the Lines: What PROMs Reveal About Itch
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
Spotlight on Assessment: Tools That Capture CKD-aP
Itching for Answers: Holistic CKD-aP Care
What You Don’t See: A Patient’s View of Living with CKD-aP